In a human study, more recently, it has been shown that in ALS patients, with alteration of the metabolic status, serum irisin levels were upregulated with respect to normo-metabolic ALS patients and control subjects [96]. The gene discussed is FNDC5; the disease is amyotrophic lateral sclerosis.